Results 121 to 130 of about 1,073 (146)

Efficacy and safety of tocilizumab in the treatment of Graves' orbitopathy: a systematic review and meta-analysis. [PDF]

BMC Endocr Disord
Chen J, Chen Y, Huang H, Duan H.
europepmc   +1 more source

Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Yeung A, Siddiqui MS, Mirtorabi N, Ahmed UN, Watts E, Sharma N, Kumari R, Boelaert K, Muzaffar J, Nieto H.   +9 more
europepmc   +1 more source

Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves' orbitopathy. [PDF]

Int J Ophthalmol
Jian H, Ma RX, He WM.
europepmc   +1 more source

[The use of tocilizumab in severe glucocorticoid-resistant endocrine ophthalmopathy with optic neuropathy in clinical practice]. [PDF]

Probl Endokrinol (Mosk)
Sviridenko NY, Ananicheva EV, Gershevich VM, Grusha YO, Chepilev KA, Surov AV, Yurgel VV, Shchukin KS, Bessmertnaya EG, Bilevich OA.   +9 more
europepmc   +1 more source

Transcriptomic Profiling of Orbital Fat Tissue and Ocular Surface Wash in Active Thyroid Eye Disease Requiring Urgent Orbital Decompression. [PDF]

Invest Ophthalmol Vis Sci
Petrácková A, Schovánek J, Karhanová M, Savara J, Nesnadná R, Kriegová E.   +5 more
europepmc   +1 more source

Quantitative evaluation of synthetic MRI for assessing disease activity in thyroid eye disease. [PDF]

Eur Radiol Exp
Zhang H, Chew SP, Xia D, Wang H, Zhang Y, Zhu L, Tao X, Li Y, Sun J, Jiang M, Zhou H.   +10 more
europepmc   +1 more source

Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survery among members of the European Thyroid Association

, 2010
Kahaly G. J., Wiersinga W. m. on behalf of EUGOGO, BARTALENA, LUIGI, Marcocci C., Krassas G., Lazarus J. H.   +5 more
core  

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

J Clin Endocrinol Metab
Wolf J, Lorenz K, Othman AE, Beck A, Michel HM, Grauhan L, Elflein H, Luffy M, Eckstein A, Lahner H, Schittkowski M, Horn M, Lagrèze WA, Bleul T, Pitz S, Vorländer C, Pieterse CC, Porter B, Clemens A, Draikiwicz S, Reinhardt M, Kahaly GJ.   +21 more
europepmc   +1 more source